spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

Tag: Boehringer Ingelheim in deal with China's Simcere Pharma to license IBD drug candidate

Boehringer Ingelheim in deal with China’s Simcere Pharma to license IBD drug candidate

German drugmaker Boehringer Ingelheim will license an experimental inflammatory bowel disease treatment ‌from China's Simcere Pharmaceutical Group, paying 42...